Fulvi-H as Possible Treatment for Viral Diseases
نویسندگان
چکیده
منابع مشابه
Novel Possible Biomarkers for the Cardiovascular Diseases Prognosis
Cardiovascular disease (CVD), especially heart failure (HF) as its common final pathway, is the leading cause of morbidity and mortality worldwide. Furthermore, oxidative and inflammatory processes represent fundamental underlying mechanisms for the development and progression of HF. Of interest, in recent years the development of markers with diagnostic and prognostic value for this pathology ...
متن کاملIII defined neurological diseases of possible viral origin
Any approach towards elucidating the aetiology of an ill defined disease such as 'epidemic neuromyasthenia' has to be a comprehensive and wide-ranging one. Although viruses must be strong candidates, by reason of their ubiquity, this need not necessarily be the case and we have recently seen the onset of Legionnaires' disease as a new entity caused by a bacterium. We do not always recognize tha...
متن کاملIll defined neurological diseases of possible viral origin.
Any approach towards elucidating the aetiology of an ill defined disease such as 'epidemic neuromyasthenia' has to be a comprehensive and wide-ranging one. Although viruses must be strong candidates, by reason of their ubiquity, this need not necessarily be the case and we have recently seen the onset of Legionnaires' disease as a new entity caused by a bacterium. We do not always recognize tha...
متن کاملENT1 and treatment of viral diseases
Ribavirin (RBV) is a synthetic nucleoside analogue (1-b-D-ribofuranosyl-1, 2,4-triazole-3-carboxamide) used for the treatment of a number of viral diseases. RBV inhibits inosine 5’-phosphate dehydrogenase (IMPDH), the enzyme required for synthesis of guanosine monophosphate (GMS) as well as DNA and RNA synthesis. Based on this mechanism of action, RBV is also used in the treatment of solid tumo...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Drug Designing: Open Access
سال: 2016
ISSN: 2169-0138
DOI: 10.4172/2169-0138.1000125